Latest in Highlight
Latest in
International pharmaceutical companies announce expansions plans in Egypt
Companies’ representatives praise MIIC, Ministry of Health’ efforts to remove any obstacles
Egypt’s Deputy Health Minister, Indian ambassador inaugurate Indian pavilion at Pharmaconex
Tamer Essam, the deputy Egyptian Health Minister, along with the Indian Ambassador to Egypt, Rahul Kulshreshth, and representatives from the Pharmaceutical Export Promotion Council of India (Pharmexcil) inaugurated the Indian pavilion at the Pharmaconex 2019 edition. The exhibition is held at the Egypt International Exhibition Center (EIEC) from 6-8 April. A delegation of Pharmexcil, comprising …
Takeda Pharmaceutical company concludes first Hodgkin lymphoma regional summit
Takeda Pharmaceutical Company held two meetings for scientific exchange and sharing experiences in relation to Hodgkin Lymphoma.
Japanese Saraya to establish $10m worth cosmetics, pharmaceutical complex in Ain Sokhna
Egypt will be major manufacturing, marketing hub for his company’s products at regional, continental levels, says Saraya president
American “Gilead Sciences” considers producing new Hepatitis C drug in Egypt
The new drug’s cure rate is 98%, and treatment period is two months: company’s director in Africa
Nasr heads Egyptian-Kazakh ministerial committee, signs cooperation protocol
Kazakhstan to support Egypt in negotiations to establish a free trade zone between Egypt and EAEU, establish joint projects
Military production ministry considers more cooperation with private sector
The ministry aims to benefit from the success of military cooperation with France to launch joint civil projects, especially in the electronics sector, says Al-Assar
Pharmaceutical companies prohibited from effacing old prices of products, companies approve
FEDCOC against the decision, will file grievance against CAPA
Banks, pharmaceutical shares expected to attract investors in 2017
The flotation of the Egyptian pound will play an influential role in determining the attractiveness of shares for investors during 2017, especially after the price of the US dollar increased to more than EGP 19, which will affect companies’ activities and their ability to make a profit. Financial and technical analysts expect that the most …
Health Ministry, pharmaceutical companies agree to increase prices of 15% of local, 20% of imported medications
The increases will be 50% on medications priced less than EGP 50, 40% on the ones less than EGP 100, and 30% on the ones priced more than EGP 100 every six months
Government meets foreign pharmaceutical company representatives to overcome medicine shortage
Companies demand government’s support in wake of higher production costs after pound’s flotation
Bayer profits soar on strong pharma business
German pharmaceutical giant Bayer has reported strong earnings and sales for the third quarter on higher demand for prescription drugs.
Bayer ups its cash offer for Monsanto
The German pharmaceutical giant has sweetened its buyout deal for Monsanto, which turned down an earlier offer. Bayer has added three dollars more per share, and it has its cash ready if the massive deal is accepted.
Mexico approves first dengue fever vaccine
Bayer profits jump in second quarter
Pharmaceutical drugs decreasing cholesterol cause muscle pain
These drugs are highly effective as they inhibit cholesterol in the liver.
Egypt closes deal with Gilead Sciences for Hepatitis C drug at 99% discount
Around 170,000 doses of Hepatitis C medicine will be available for Egyptian patients late September
Pharmaceutical leader calls for hike in drug prices
Novartis’s vice-president also called for the Ministry of Health to formulate a clear system to guarantee the delivery of modern and innovative drugs as quickly as possible and at the appropriate prices.
Egyptian medical products to be high priority in Lebanese market
Lebanese authorities would now begin giving high priority to Egyptian products entering the Lebanese market.